The pharmaceutical giant has not demonstrated a substantial likelihood of success on the merits as to any of its claims against Mississippi’s law (H.B.728), according to an opinion from Judge Louis Guirola Jr. at the US District Court for the Southern District of Mississippi.
At issue before the court was whether the law, which outlaws any effort to deny, restrict, or prohibit drug discounts to pharmacies that contract with providers ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.